LSm2 Activators

LSm2 Activators are compounds that can modulate the activity or expression of LSm2, an integral protein associated with mRNA degradation. Actinomycin D affects RNA synthesis by intercalating DNA, subsequently impacting LSm2's role in RNA processing. DRB inhibits RNA polymerase II, influencing mRNA synthesis and LSm2's function in mRNA degradation. α-Amanitin further impacts the role of LSm2 by inhibiting RNA polymerase II, thus altering RNA synthesis. MG-132 influences the stability or interactions of LSm2 by affecting protein turnover and degradation.

Leptomycin B alters the localization and function of proteins like LSm2 due to its ability to inhibit nuclear export. 5-Azacytidine is considered in this class as it influences RNA processing and modification, thus affecting LSm2's role in mRNA degradation. Another significant compound, JQ1, impacts LSm2 activity by affecting gene expression as it acts as a BET bromodomain inhibitor. Compounds such as Cycloheximide, Trichostatin A, SAHA, Rapamycin, and Oligomycin A complete this category, each altering specific cellular processes or pathways, ranging from protein synthesis and gene expression to ATP synthesis and cellular energy status, impacting the functionality and activity of LSm2 in diverse ways.